#+TITLE: Congenital Disorders of Glycosylation
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today

:PROPERTIES:
#+DRAWERS: PROPERTIES
#+LaTeX_CLASS: beamer
#+LaTeX_CLASS_OPTIONS: [presentation, smaller]
#+BEAMER_THEME: Hannover
#+BEAMER_COLOR_THEME: whale
#+COLUMNS: %40ITEM %10BEAMER_env(Env) %9BEAMER_envargs(Env Args) %4BEAMER_col(Col) %10BEAMER_extra(Extra)
#+OPTIONS: H:2 toc:nil ^:t
#+PROPERTY: header-args:R :session *R*
#+PROPERTY: header-args :cache no
#+PROPERTY: header-args :tangle yes
#+STARTUP: beamer
#+STARTUP: overview
#+STARTUP: indent
# #+BEAMER_HEADER: \subtitle{Part 1: Maple Syrup Urine Diseas}
#+BEAMER_HEADER: \institute[NSO]{Newborn Screening Ontario | The University of Ottawa}
#+BEAMER_HEADER: \titlegraphic{\includegraphics[height=1cm,keepaspectratio]{../logos/NSO_logo.pdf}\includegraphics[height=1cm,keepaspectratio]{../logos/cheo-logo.png} \includegraphics[height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}}
#+latex_header: \hypersetup{colorlinks,linkcolor=white,urlcolor=blue}
#+LaTeX_header: \usepackage{textpos}
#+LaTeX_header: \usepackage{textgreek}
#+LaTeX_header: \usepackage[version=4]{mhchem}
#+LaTeX_header: \usepackage{chemfig}
#+LaTeX_header: \usepackage{siunitx}
#+LaTeX_header: \usepackage{gensymb}
#+LaTex_HEADER: \usepackage[usenames,dvipsnames]{xcolor}
#+LaTeX_HEADER: \usepackage[T1]{fontenc}
#+LaTeX_HEADER: \usepackage{lmodern}
#+LaTeX_HEADER: \usepackage{verbatim}
#+LaTeX_HEADER: \usepackage{tikz}
#+LaTeX_HEADER: \usepackage{wasysym}
#+LaTeX_HEADER: \usetikzlibrary{shapes.geometric,arrows,decorations.pathmorphing,backgrounds,positioning,fit,petri}
:END:

#+BEGIN_EXPORT LaTeX
%\logo{\includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/NSO_logo_small.pdf}~%
%    \includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}%
%}

\vspace{220pt}
\beamertemplatenavigationsymbolsempty
\setbeamertemplate{caption}[numbered]
\setbeamerfont{caption}{size=\tiny}
% \addtobeamertemplate{frametitle}{}{%
% \begin{textblock*}{100mm}(.85\textwidth,-1cm)
% \includegraphics[height=1cm,width=2cm]{cat}
% \end{textblock*}}
#+END_EXPORT 

* Introduction

** Introduction

- Most extracellular proteins, such as serum proteins, most membrane proteins and several intracellular proteins (such as lysosomal enzymes), are glycoproteins.
- The glycans are defined by their linkage to the protein:
  - N-glycans are linked to the amide group of asparagine
  - O-glycans are linked to the hydroxyl group of serine or
    threonine.

- Glycosylphosphatidylinositol (GPI) anchors are glycolipids that
  tether more than 150 proteins to the outer leaflet of plasma
  membranes.

- Congenital disorders of glycosylation are due to defects in the
  synthesis of glycans and in the attachment of glycans to proteins
  and lipids.
- Rapidly growing disease family ~ 

** Synthesis of N-glycans

1) Formation in the cytosol of nucleotide-linked sugars, mainly
   GDP-Man, and also UDP-Glc and UDP-GlcNAc followed by attachment of
   GlcNAc and Man units to dolichol phosphate, and flipping of the
   nascent oligosaccharide structure into the ER.
2) Stepwise assembly in the ER, by addition of Man and Glc resulting
   in the 14-unit oligosaccharide precuror:
   - dolichol pyrophosphate-N-acetyl-glucosamine_2 -mannose_9 -glucose_3
3) Transfer of this precursor onto the nascent protein, followed by
   final processing of the glycan in the Golgi apparatus by trimming
   and attachment of various sugar units.

** N-glycan Assembly

#+CAPTION[]:N-glycan assembly
#+NAME: fig:ngassembly
#+ATTR_LaTeX: :width 0.9\textwidth
[[file:./figures/ngassembly.png]]

** N-glycan Remodelling

#+CAPTION[]:N-glycan remodelling
#+NAME: fig:ngremodel
#+ATTR_LaTeX: :width 0.9\textwidth
[[file:./figures/ngremodel.png]]

** CDGs


* CDG-1a
CDG-Ia accounts for 70% of the congenital disorders of glycosylation, which combined affect 1 in every 50,000 to 100,000 births. Cases of CDG-Ia have been reported worldwide, with about half coming from Scandinavian countries
